Rituximab for High-Risk, Mature B-Cell Non-Hodgkin’s Lymphoma in ChildrenVéronique Minard‐Colin, Thomas G. Gross, Anne Uyttebroeck et al.|New England Journal of Medicine|2020Cited by 308
Essential medicines for childhood cancer in Europe: a pan-European, systematic analysis by SIOPEMaria Otth, Elena Oltenau, Eva Brack et al.|The Lancet Oncology|2022Cited by 10
Dinutuximab Beta Added to Temozolomide-Based Chemotherapy for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON Immuno Phase II TrialJuliet C. Gray, Lucas Moreno, Rebekah Weston et al.|Journal of Clinical Oncology|2025Cited by 8
Clinical utility of vinblastine therapeutic drug monitoring for the treatment of infantile myofibroma patients: A case seriesVickyanne Carruthers, Gareth J. Veal, S. Barnett et al.|Pediatric Blood & Cancer|2022Cited by 4